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Abstract 44 
As obesity incidence is alarmingly rising among young individuals, we aimed to 45 
characterize an experimental model of this situation, considering the similarity between 46 
human and porcine physiology. For this reason, we fed prepubertal (63 days-old) Duroc 47 
breed females (n=20) either with a standard growth diet (3800 KCal/day) or one with a 48 
high-calorie content (5200 KCal/day) during 70 days. Computerized tomography, mass-49 
spectrometry based metabolomics, and lipidomics, as well as peripheral blood 50 
mononuclear cell transcriptomics, were applied to define traits linked to high-calorie 51 
intake. Samples from a human cohort confirmed potential lipidomic markers. Compared 52 
to those fed a standard growth diet, pigs fed a high-calorie diet showed an increased 53 
weight gain (13%), much higher adiposity (53%), hypertriacylglyceridemia and 54 
hypercholesterolemia, in parallel to insulin resistance. This diet induced  marked 55 
changes in the circulating lipidome, particularly in phosphatidylethanolamine-type 56 
molecules. Also, circulating specific diacylglycerol and monoacylglycerol contents 57 
correlated with visceral fat and intrahepatic triacylglycerol concentrations. Specific lipids 58 
associated with obesity in swine (mainly belonging to glycerophospholipid, 59 
triacylglyceride, and sterol classes) were also linked with obesity-traits in the human 60 
cohort, reinforcing the usefulness of the chosen approach. Interestingly, no overt 61 
inflammation in plasma or adipose tissue was evident in this model. The presented model 62 
is useful as a preclinical surrogate of prepubertal obesity in order to ascertain the 63 
pathophysiology interactions between energy intake and obesity development. 64 
1. INTRODUCTION 65 
Childhood obesity is linked to severe metabolic derangements in adult life [1]. 66 
Epidemiological studies reveal alarming rates of incidence of prepubertal and pubertal 67 
obesity [2], with its worrying impact on insulin resistance, development of type 2 diabetes, 68 
increased cardiometabolic risk, decreased bone health, as well as the psychological 69 
consequences of this derangement[3]. Therefore, the burden of increased caloric 70 
unbalance could seriously affect pubertal and postpubertal health[1].  71 
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 72 
Obesity is considered a multifactorial situation [4]. Under an evolutionary point of view, 73 
adipose tissue (AT) buildup in mammals can be a physiological response over changes 74 
in calorie availability, with a signaling role [5,6], which could be useful for homeostasis in 75 
an environment with energy availability oscillations. As such, increased fat content is not 76 
always linked to metabolic derangements [7]. The continuum between these two 77 
situations is still mostly unknown, leading to the uncertainty on why some individuals 78 
develop insulin resistance and enhanced cardiometabolic risk even with lack of AT build-79 
up (metabolically unhealthy lean people) whereas other can cope with high amounts of 80 
adipose tissue (metabolically healthy obese) [8]. It is required an adequate 81 
characterization, at a molecular level, of the events between AT accumulation and its 82 
consequences, to fill this gap of knowledge. 83 
 84 
In this line, available experimental models of obesity show some intrinsic limitations. For 85 
instance, rodents could exhibit increased obesity when placed in high-calorie intake, 86 
especially in the so-called cafeteria diet (e.g., an unbalanced diet with high fructose or 87 
high lipid content). Interestingly, due to the close physiological resemblance of porcine 88 
and human physiologies, specific cardiometabolic markers translate better in pigs than 89 
in rodent models. These include low HDL-cholesterol, increased LDL-cholesterol, 90 
coronary calcification, to name a few. Thus, in both primates and swine, lipoprotein 91 
metabolism is very similar to humans [9,10]. Therefore, unhealthy diets in these species 92 
are able to induce changes in lipid profiles associated with cardiometabolic risk, 93 
reproducing many changes present in humans [10,11]. Pigs are particularly suited for 94 
evaluating their lipid metabolism, based on the knowledge of genetic traits controlling 95 
them, and the possibility to monitor the buildup of AT by using clinical imaging systems 96 
as computed tomography (CT)[12,13]. 97 
  98 
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Systems biology has helped to unravel the pathogenic role of specific fat depots in both 99 
humans and rodents. Among involved disciplines, proteomics, metabolomics, and 100 
lipidomics are closely interlaced with the phenotype, offering a dynamic view of the 101 
ongoing molecular changes. Metabolomics either focused on polar molecules or 102 
lipidomics (when lipids are extracted before the analyses), have the advantage of 103 
covering a high number of potential candidate biomarkers. When combined adequately 104 
with confirmatory techniques, they could disclose pathogenic pathways amidst 105 
generating novel hypotheses for diagnosis, prognosis, and therapeutics. 106 
 107 
In this context, the present work aims to characterize molecular traits associated with the 108 
obesity induced by a high-calorie diet in prepubertal female pigs. This goal is achieved 109 
by combining an imaging platform based on CT evaluation of AT distribution, weight 110 
evolution, food intake with changes in circulating lipidome and metabolome, with a view 111 
of specific transcripts in the subcutaneous AT and in the transcriptome of the peripheral 112 
blood mononuclear cells (PBMCs). These later were chosen as they may share, at least 113 
partially, share the expression profile of different sets of genes with other tissues, 114 
including those that reflect metabolic responses[14–16]. Furthermore, the lipidomic 115 
changes were validated in a cohort of human subjects to confirm the robustness of these 116 
observations. Finally, these changes were compared with clinically validated biomarkers 117 
of obesity-related dyslipidemia with some of the suggested pathogenic pathways 118 
confirmed in adipose and liver tissues. 119 
 120 
2. METHODS 121 
All the experimental procedures with pigs, including management, traits recording, 122 
monitoring, and blood sampling, were approved by the Ethical Committee of the Institut 123 
de Recerca i Tecnologia Agroalimentàries (IRTA, Girona, Spain). In the case of human 124 
samples, these were obtained from the FLORINASH study cohort [17], and its 125 
institutional review board approved the study protocol, and all subjects provided informed 126 
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written consent. Briefly, we recruited 44 consecutive subjects. Inclusion criteria were age 127 
30–65 years and acceptance to study procedures. Exclusion criteria were a systemic 128 
disease, infection in the previous month, chronic severe illness, ethanol intake >20 g/day, 129 
or use of medications that might interfere with insulin action. For comparison with porcine 130 
model-derived biomarkers, we recorded body to mass index (BMI) and homeostatic 131 
model assessment for insulin resistance (HOMA-IR). See supplemental Table 1 for 132 
clinical characteristics (supplemental data). Sources for chemicals are also presented in 133 
the extended Methods section (supplemental data). 134 
2.1 Animals and treatments 135 
A total of 21 female piglets from a high intramuscular fat Duroc pig line were used in the 136 
present study. Animals were born in 10 different litters (i.e., ten pairs of littermates) and 137 
were distributed randomly to one of the two diets (conventional diet for growth and 138 
western-type, see below). After weaning, piglets were transferred to the IRTA pig 139 
experimental test station and subjected to the same management procedures. From 140 
weeks 9 to 11, animals were adapted to a transition diet (Supplemental Tables 2 and 3). 141 
Subsequently, each of the sibling pairs was divided into the two dietary treatments: 142 
animals fed a conventional growth diet and animals fed a western-type diet with a high-143 
calorie, high-sucrose and low fiber content (detailed composition and nutritional 144 
properties shown in supplemental Tables 4 and 5, ). The experiment lasted until pigs 145 
reached 19 weeks of age when animals were sacrificed after an overnight fast, at IRTA 146 
experimental slaughterhouse compliance with all welfare regulations. Pigs were weighed 147 
individually at the beginning and every two weeks during the whole experiment, plus the 148 
day before slaughter. Daily feed intake (FI; kg/day) was recorded individually through 149 
theautomatic electronic feeding system HOKOFARM-IVO-G ® (Marknesse, The 150 
Netherlands): all animals are identified electronically and located in contiguous pens in 151 
the same barn (with 10 – 11 animal groups of littermates). Each pen is provided with an 152 
automatic feeding recording system (system HOKOFARM-IVO-G ®), allowing full control 153 
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of individual voluntary ad libitum feed intake. Each particular meal intake ( 10 to 20 per 154 
day) is recorded, and the full dailyfeed ingested amount is computed for each animal (as 155 
well as the number and duration of meals).  Blood samples for biochemical and 156 
transcriptome analyses were taken from fasted animals immediately before sacrifice. 157 
After slaughtering, pelvic-renal fat (flare fat) was removed and weighted.   158 
2.2 Computed tomography scanning and image analysis 159 
All pigs were CT-scanned one week before sacrifice employing the General Electric 160 
HiSpeed ZX/I (Fairfield, CN, USA) equipment located at IRTA in Monells (Girona,Spain) 161 
as explained in [12] and images were analyzed using software VisualPork [18,19] 162 
developed by the University of Girona and IRTA. See Figure 1A and 1B as an example 163 
of employed images. See the extended Methods section (supplemental data) for further 164 
description. 165 
 166 
2.3 Biochemical analyses and western blot  167 
Serum lipids and other conventional biochemical variables were measured in fasted 168 
animals in blood obtained immediately before sacrifice by using commercial kits, 169 
including triacylglycerides, total cholesterol, LDL- cholesterol, HDL cholesterol, and 170 
glucose, as described previously [20]. Plasma interleukin concentrations were measured 171 
using Millipore multiplex kits for porcine samples (Millipore, Barcelona, Spain) according 172 
to manufacturer instructions. Plasma insulin content was measured using a commercial 173 
ELISA kit (Abcam, Cambridge, UK). Total lipids were extracted from the liver (80 mg) 174 
and dried feces (100 mg) of the pigs and were quantified using the methods previously 175 
described [21]. In the liver and feces samples, triglycerides and cholesterol were 176 
quantified by colorimetric kits (QCA, Barcelona, Spain). Western blot analyses of tissues 177 
were performed as described[20] and explained in the extended Methods section 178 
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(supplemental data), using as primary and secondary antibodies those listed in 179 
supplemental Table 6 (supplemental data).  180 
2.4 Untargeted lipidomic analyses of plasma 181 
Plasma lipidomic analysis was based on a previously validated method [22]. Internal 182 
standards (listed in supplemental Table 7), lipid extraction, and lipidomic techniques are 183 
explained in the extended Methods section (supplemental data). Lipid extracts were 184 
subjected to liquid chromatography coupled to mass spectrometry (LC-MS) using an 185 
Agilent UPLC 1290 coupled to the Q-TOF MS/MS 6520 (Agilent Technologies, 186 
Barcelona, Spain) based on a previously published method [23]. 187 
2.5 Untargeted metabolomics analyses of serum 188 
The metabolomic analyses of serum extracts were performed by LC-MS and further 189 
explained in the extended Methods section (supplemental data).  190 
2.6 Peripheral blood monocyte cells (PBMC) transcriptomics and AT leptin 191 
expression 192 
PBMCs transcriptomics was done of (n=7 from each group) at the Centre for Omic 193 
Sciences (Reus, Spain) by using the Porcine (V2) Gene Expression Microarray, 4x44K 194 
(Agilent Technologies) following manufacturer’s instructions. AT mRNA expression in 195 
the subcutaneous depot was quantified as previously described [24] by using real-time 196 
PCR in a LightCycler 480 Real-Time PCR System (Roche Diagnostics) using TaqMan® 197 
technology suitable for relative gene expression quantification. Both methods are further 198 
developed in the extended Methods section (supplemental data). 199 
2.7 Data processing, Network, and Statistic Analyses  200 
In the case of lipidomics and metabolomics, the MassHunter Data Analysis Software 201 
(Agilent Technologies) was used to collect the results and the MassHunter Qualitative 202 
Analysis Software (Agilent Technologies) to obtain the molecular features of the 203 
samples, representing different, co-migrating ionic species of a given molecular entity 204 
(i.e., ion adducts) using the Molecular Feature Extractor algorithm (Agilent Technologies) 205 
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[25]. This algorithm uses the accuracy of the mass measurements to group related ions 206 
(based on the charge-state envelope, isotopic distribution, and the presence of different 207 
adducts and dimers/trimers) assigning multiple species (ions) to a single compound 208 
referred to as a feature. Finally, the MassHunter Mass Profiler Professional Software 209 
(Agilent Technologies) was used to perform a non-targeted analysis over the extracted 210 
features. Only shared features (found in at least 75% of the samples of the same 211 
condition) were taken into account to correct for individual bias. In the case of non-212 
targeted lipidomics, proposed annotation by lipid class is based on exact mass, isotopic 213 
distribution, and retention time of lipid family standards, so fatty acid distribution offered 214 
is one of the potential combinations leading to the same number of carbons and 215 
unsaturations. 216 
 In the case of non-targeted metabolomics, the identification of detected compounds with 217 
significant differences was performed based on the exact mass, the adduct formation, 218 
and the isotopes relative abundance and spacing using the Metlin/PCDL database and 219 
Molecular Formula Generation software (Agilent Technologies).  220 
In case of lipidomics, after log transformation and auto-scaling of variables, the masses 221 
representing significant differences by Student’s t-test (p < 0.05 with false discovery rate 222 
correction) were searched against the LIPID MAPS database (The LIPID MAPS 223 
Lipidomics Gateway, http://www.lipidmaps.org/, February 2018) (exact mass ppm < 20).  224 
 225 
All other analyses were performed either with the SAS software ver. 9.4 (SAS Institute 226 
Inc., Cary, NC, USA), with the Prism ver 7 (GraphPad Software, La Jolla, CA, USA) or 227 
with the SPSS software ver 24 (IBM Corp, Armonk, NY, USA). Non-linear fit (exponential 228 
growth equations; Y=Y0*exp(k*X)) lines in the graphs correlating two variables were 229 
produced with the Prism software. Multivariate statistics (Hierarchical Clustering, PCA, 230 
and PLS-DA analyses) were done using the Metaboanalyst platform software [26]. Gene 231 
enrichment and induced network module analyses were performed in the 232 
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ConsensusPathDB platform [27]using as input genesagtpbp1, fcrl4,herc4,egr2, 233 
loc780435, loc100622399, loc100621244, krt18, ly49, pth, kctd14, ppp1r36, and trim46. 234 
The same list was also explored with the Genemania platform[28], using Homo sapiens 235 
(human) as the reference and searching for its potential relationship with genes in lipid 236 
metabolism pemt and srbep1.  237 
 238 
3. RESULTS 239 
As expected, animals under the  western-type regime increased weight in a significant 240 
amount (Table 1). However, despite these animals ingested near 37% more calories per 241 
day, the difference in weight did not reach these changes, only achieving 13% more 242 
weight. This ponderal change was also associated with an increased fecal fat content (in 243 
cholesterol and triacylglyceride content). Nonetheless and despite these data pointing 244 
for a trend for fecal lipid loss, adiposity, measured by CT imaging, increased sharply, 245 
reaching ca two fold increases in AT derived parameters, such as relative fat volume and 246 
pelvic-renal fat content. Concerning biochemical consequences associated with obesity, 247 
animals under the high-calorie regime increased plasma cholesterol significantly, its 248 
subfractions, and triacylglyceridemia in parallel to insulin resistance (HOMA-IR, ca 43%, 249 
p<0.01), suggesting an early impairment in glucose homeostasis (Table 1).  250 
 251 
To enhance the knowledge of the molecular basis of this phenotype, we performed a 252 
non-targeted lipidomic analysis in plasma samples. This approach shows that 253 
prepubertal obesity changed the amounts of 187 molecules (p values ranging between 254 
1.49E-20 and 0.05; Supplemental dataset 1), with very significant changes in 23 255 
compounds (FDR <0.1). These comprised 4 phosphatidylethanolamines and a 256 
cerebroside, among the top markers. Hierarchical clustering resulted in a clear 257 
separation between the two lipidomes using the 25 most statistically significant 258 
molecules (Figure 1C) with a PLS-DA model (Figure 1D) with high accuracy (71%, with 259 
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R2=0.92 in a one model component, Supplemental Figure 1). Variable importance in 260 
projection scores reinforced the importance of several phosphatidylethanolamine and 261 
phosphatidylserine molecules in the first component, with a cerebroside, a 262 
monoacylglycerol and a sterol related molecule among these discriminating features 263 
(Supplemental Figure 1).  264 
 265 
We studied if specific circulating lipids correlated with individual parameters affecting 266 
final weight since the high-calorie intake impacted differently on each individual (e.g., 267 
variances higher than 10% in the final weight, Table 1). Concerning calorie consumption, 268 
218 molecules correlated significantly with calorie intake (p values ranging between 269 
7.61E-7 and 0.05, Spearman rank correlation between absolute values between 0.85 270 
and 0.42, Supplemental Dataset 2). Among these, three phosphatidylethanolamines 271 
were among the top targets correlating with calorie intake (Figure 1D). Interestingly, 272 
several molecules also correlated with AT content (226 molecules, with p values 273 
between 6.8 E-6 and 0.05, Spearman rank absolute correlation values between 0.81 and 274 
0.43, Supplemental Dataset 3). Besides phosphatidylethanolamines, other lipids showed 275 
a high correlation, such as a monoglyceride and a cerebroside (Figure 1E). The targets 276 
correlating with pelvic-renal AT depot abundance were different from those of total fat, 277 
suggesting the fact that non-subcutaneous fats constitute depots with unique 278 
pathophysiological traits. Thus, 169 different molecules correlated with pelvic-renal 279 
depot abundance (p values between 5.9E-5 and 0.05, Spearman rank absolute 280 
correlation values between 0.76 and 0.43, Supplemental Dataset 4). Though 281 
phosphatidylethanolamines were correlated as well, top molecules belonged to 282 
cholesteryl esters and to phosphatidylserine (Figure 1F).  283 
 284 
Interestingly and independently from lipidomic changes in plasma, a partial least square 285 
discriminant analyses (PLS-DA) model encompassing AT depots and lipidemia variables 286 
((plasma, liver, and LDL cholesterol) exhibit a high accuracy (Supplemental Figure 2A). 287 
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Clustering analyses showed that not all the adipose tissue depots clusterized together, 288 
with pelvic-renal fat being associated with lipidemia variables, (Supplemental Figure 2B). 289 
In contrast, total fat and subcutaneous fat depot were more closely associated with 290 
calorie intake and final weight. Variable importance in projection (Supplemental Figure 291 
2C) showed that the most influential variables were calorie intake, total fat, and 292 
subcutaneous fat percentages. Permutation tests demonstrated the robustness of this 293 
model (Supplemental Figure 2D).  294 
 295 
As LDL cholesterol was also affected by western-typeregime, we evaluated potential 296 
lipidomic markers linked to this biochemical trait. Interestingly, these differed from those 297 
correlated with other biochemical characteristics. Thus, 165 molecules correlated with 298 
LDL cholesterol concentrations (p values between 2.5 E-5 and 0.05, Spearman rank 299 
correlation absolute values between 0.71 and 0.43, Supplemental DataSet 5). These 300 
molecules comprised a specific phosphatidylethanolamine (different from the one 301 
correlated with fat contents) and several unknown lipids (Supplemental Figure 3). 302 
 303 
As increased fasting glycemia and HOMA-IR (despite no overt hyperinsulinemia) were 304 
evidenced in this model of prepubertal obesity, we searched for lipidomic markers of 305 
insulin resistance. Insulin concentrations were correlated with 90 different lipids (p values 306 
between 0.0003 and 0.05, Spearman rank absolute correlation values between 0.68 and 307 
0.43, Supplemental Dataset 6). Specific molecules comprised a phosphatidic acid and a 308 
lactosyl-ceramide (Figure 2A). Similarly, a total of 77 molecules correlated with HOMA-309 
IR (p values between 0.0002 and 0.05, Spearman rank absolute correlation values 310 
between 0.75 and 0.46, Supplemental Dataset 7). These included specific 311 
triacylglycerides and sphingolipids (Figure 2A). Insulin acts on adipogenesis via specific 312 
effectors such as SREBP1 [29]. Although we did not observe overt hyperinsulinism but 313 
insulin resistance, we evaluated insulin-dependent signals in adipose tissues of this 314 
model. The results demonstrate anatomic differences in the impact of a high-calorie diet 315 
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in insulin signaling modules of adipose tissue. Both adipose tissues from pelvic-renal 316 
and omental locations showed a significantly increased amount of SREBP1c, while 317 
subcutaneous and omental ATs locations showed decreased Glut4 levels, consistent 318 
with insulin resistance (Figure 2B). Of note, AT in the pelvic-renal location did not show 319 
detectable levels of Glut4 (data not shown), but Glut2. We also evaluated the expression 320 
of specific mRNs in the subcutaneous depot (Supplemental Table 8). We studied which 321 
of the circulating lipids correlated with leptin expression since leptin levels mirror 322 
adipogenesis in subcutaneous depot (significantly increased by evaluation of its mRNA 323 
content in 186%, p<0.00001). The results demonstrate significant associations of leptin 324 
mRNA levels in subcutaneous AT and 138 lipids in plasma (p values between 4.92E-05 325 
and 0.049, Spearman rank correlation absolute values between 0.76 and 0.43, 326 
Supplemental Dataset 8). These include specific phosphatidylethanolamine and 327 
triacylglycerides (Figure 2C). The specificity of the lipidomic changes associated with 328 
insulin signaling is evidenced by the lack of common lipidomic correlations with leptin 329 
mRNA and very low common correlations with fat content (Figure 2D). 330 
As the liver is also a target of obesity, we evaluated the potential occurrence of hepatic 331 
steatosis in this model. The results show that the western-type diet in this model did not 332 
change  neither triacylglycerides  nor cholesterol content  (Supplemental Figure 4). 333 
Despite no significant changes were measured in phosphorylated-IRS1 (Ser 307, Ser 334 
1101) or in phosphorylated c-Jun (Ser 73) (supplemental Figure 4) decreased Glut2 335 
content potentially marked incipient insulin resistance, (Figure 3A), with some circulating 336 
lipids correlating significantly with changes in hepatic fat content. Thus, 123 molecules 337 
correlated with hepatic triacylglyceride  content (p values between 1E-4 and 0.05, 338 
Spearman rank absolute correlation values between 0.74 and 0.43, Supplemental 339 
Dataset 9). These comprised a diacylglycerol and a phosphatidic acid (Figure 3B). 340 
Plasma species correlating with liver triacylglyceride content are quite specific (Figure 341 
3C). Noteworthy, changes in glucose transporters did not affect, at this stage, skeletal 342 
muscle (Supplemental Figure 5). 343 
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 344 
In line with the moderate impact of high calorie in this model, plasma values of measured 345 
interleukins did not demonstrate overt inflammation (Supplemental Table 9). However, 346 
statistically significant correlations were present between circulating lipids and selected 347 
interleukins, including IL-1a, IL-1b, and IL-18 (Supplemental figure  6, supplemental 348 
Dataset 10 for correlated lipids). These lipids comprised specific 349 
phosphatidylethanolamines, triacylglycerides, and tocopherol derivates. 350 
 351 
To evaluate whether this model could be of usefulness in human obesity, we compared 352 
the results with those obtained from plasma lipidomic analyses of a human cohort. As 353 
Figure 4 shows, there is a consistent overlap between the behavior of selected 354 
biomarkers of obesity and its metabolic consequences between these two species. Thus, 355 
selected phospholipid molecules (phosphatidylserine (21:0, 22:0), sterols (5-cholestan-356 
3-one), and unidentified lipids correlated significantly both with BMI in humans and with 357 
fat abundance in pigs. Interestingly, other lipids also correlated with HOMA-IR in both 358 
species, underlying the usefulness of the chosen model. The same behavior was 359 
observed for correlations between cerebroside D, N-(11Z,14Z-eicosadienoyl)-360 
ethanolamine, TG (16:0/16:1(9Z)/16:1(9Z)) and BMI (R2=0.31, p<0.0001; R2=0.09, 361 
p<0.03; R2=0.12, p<0.02 after Pearson correlation analyses), as presented in 362 
Supplemental Figure 7. 363 
 364 
To further characterize the impact of western-type diet in the porcine model, we also 365 
analyzed changes in the aqueous soluble phase of serum and explored changes in the 366 
PBMC transcriptome profile. Globally speaking, the number of differential features was 367 
much lower comparing the aqueous extracts with those of organic solvents 368 
(Supplemental Table 8). When aggregating these changes of metabolites into pathways, 369 
these defined a network that comprised variations in metabolites belonging to branched-370 
chain amino acids (BCAA), central carbon metabolism, and pantothenate and coenzyme 371 
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A synthesis (Figure 5). Changes in PBMC transcriptome (Supplemental Dataset 11), 372 
when mapped, revealed two main networks affected by high-calorie intake 373 
(Supplemental Figure 8). One was related to EGR2, and the other was mainly paired 374 
with KRT18 and RAAR genes. The functional annotation of these genes clustered in 4 375 
different enriched neighborhood-based tests (p<0.001), which included SUV420H2, 376 
DTX4, DTX1, and USP49 (Supplemental Figure 9). We also evaluated the potential 377 
network proximity between genes in PBMC transcriptome and key genes in metabolism, 378 
SREBP1, and PEMT. These two later belonged to the network of expression of KRT18 379 
and EGR2   (Supplemental figure 10).   380 
 381 
4. DISCUSSION 382 
The present work reinforces the usefulness of high-calorie regimes in porcine models to 383 
evaluate obesity pathophysiology [30,31]. Interestingly, we found that the body weight 384 
gain induced by high calorie, although significant, was not proportional to calorie intake. 385 
This fits with the notion that weight gain and calorie intake are not linear[32]. In rats, 386 
physical activity, among other factors, could divert dietary fats towards oxidation and less 387 
to the storage, in a manner associated with de novo lipogenesis in adipose tissue, as 388 
well as increases in skeletal muscle uptake and oxidation of lipids [33]. This metabolic 389 
switch seems not uncommon in swine [34]. Of note, fat content increased in the high-390 
calorie group. In any case, our model can be viewed as an early obesity model, with 391 
some traits of metabolic syndrome. This resemblance with human pathology has been 392 
already described for domestic pigs under similar, high-fat regimes, where short term 393 
interventions led to weight gain and dyslipidemia, but not tovert insulin resistance or 394 
metabolic syndrome[35]. Several factors may explain the relatively small metabolic 395 
impact in the current porcine model in comparison to other reported porcine models, 396 
including the age of the individuals, the lack of a large amount of refined sugars (fructose 397 
or sucrose), in comparison to other diets inducing obesity in porcine models, the specific 398 
breed or the length of treatment.  399 
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 400 
In order to characterize the molecular traits explaining these obesity-related changes, 401 
we performed non-targeted lipidomic analyses of plasma samples. For the sake of 402 
brevity, we will limit mainly the discussion of those results obtained after FDR correction. 403 
The results suggest the role of specific phosphatidylethanolamines as potential obesity 404 
circulating biomarkers at a molecular level. One of the most differential identifiable 405 
markers is a dimethylphosphatidylethanolamine. These products are intermediates in 406 
the liver synthesis of phosphatidylcholine de novo biosynthesis through methylation of 407 
phosphatidylethanolamine, especially relevant when choline is deficient in diet [36]. This 408 
conversion is catalyzed by the enzyme phosphatidylethanolamine N-methyltransferase 409 
(PEMT), whose activity is regulated by adenosylmethionine and 410 
phosphatidylethanolamine levels. Since this activity is essential for VLDL secretion, we 411 
hypothesize that increased levels of the dimethylphosphatidihylethanolamine detected 412 
could be a proxy for increased PEMT activity in the liver and VLDL secretion, required 413 
for exporting hepatic lipids towards their adipose depot. PEMT loss renders protection 414 
over diet-induced obesity[37], suggesting that in our model of obesity, this activity is 415 
increased. Noteworthy, PEMT expression and colocalization are related with EGR2 and 416 
KRT18, as pathway analyses show.  Other lipids significantly related to energy intake, 417 
were specific phosphatidylethanolamine (PE) with long fatty acids. These findings could 418 
go in line with data from lipidomic analyses of plasma from overweight and obese healthy 419 
individuals [38]. In these analyses, other PE species appeared to be relevant 420 
components of a plasma lipidomic signature of obesity. Interestingly, in other cohorts of 421 
patients with prediabetes and diabetes, increased PE levels were noted as well [39]. In 422 
this context, these were interpreted as a source for inflammatory eicosanoids, which may 423 
be as well our case, as one of the potential fatty acids present in these PE is arachidonic 424 
acid. Other works revealed an association of a specific PE, containing 40:6 fatty acids, 425 
with insulin resistance in human individuals[40].  426 
 427 
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Reinforcing the validity of porcine lipid metabolism in the context of human obesity, 428 
increases in specific PE-related species[41], such as plasmalogens, were observed in 429 
obese subjects. Plasmalogens are part of an antioxidant response towards increased 430 
oxidative stress with high-calorie intake. Nonetheless, several phospholipids 431 
(phosphatidylserine and sterol molecules) correlated with BMI and AT  abundance in 432 
both species using the same methodological approach. 433 
 434 
Other lipids were significantly associatedwith adiposity, measured by CT imaging. Thus, 435 
increases in a long chain monoacylglycerol were detected. In mice, the deletion of one 436 
of the enzymes linked to monoacylglycerol degradation, monoacylglycerol lipase, leads 437 
to increased concentrations of monoacylglycerol and resistance to obesity, as well as 438 
delayed lipid absorption [42]. The increased levels detected here may be viewed as a 439 
potential homeostatic downregulation of monoacylglycerol lipase activity. Another lipid 440 
showing a similar behavior with adiposity, cerebroside D, has been reported to be a 441 
potent immunomodulatory agent in mice models of experimental colitis[43]. Furthermore, 442 
glucocerebrosides afford protection over the metabolic syndrome induced by leptin loss 443 
in mice [44]. It is known that structurally related compounds, such as glucosylated 444 
ceramides and ceramides, play critical roles in insulin resistance, which has an 445 
inflammatory background [45], therefore increased cerebroside D might be viewed as a 446 
compensatory response to avoid the high-energy induced inflammatory burden. Of note, 447 
cerebroside D was also found in the humane cohort used for the translational applicability 448 
of the model, thereby reinforcing its potential importance in obesity pathophysiology. 449 
 450 
 In line with the pathophysiological relevance of the location of adipose tissue depots 451 
[24], the lipids that correlated with total adiposity were different from those correlating 452 
with the amount of pelvic-renal fat depot, a typical visceral location. Cholesteryl ester 453 
18:3, associated with the amount of this AT, has been previously shown to be decreased 454 
in a murine model of obesity [46]. However, and reinforcing the similarity of porcine 455 
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models with humans, a sizeable lipidomic survey revealed a significant association of 456 
cholesteryl esters with body mass index in humans[47]. The other lipid, a  457 
phosphatidylserine, has not been previously related to obesity, but instead to 458 
preeclampsia in humans[48]. Glycerophosphoserines play vital structural roles in cell 459 
membranes [49], where they may regulate oxidative stress responses and apoptosis, 460 
but so far, it was not associated with high energy intake. Of note, a glycerophosphoserine 461 
was found among the biomarkers shared between the porcine study and the humane 462 
cohort. These lipids have been linked recently to changes in postprandial lipidome after 463 
physical activity in humans with type 2 diabetes [50]. 464 
 465 
Finally, phosphatidic acid and diacylglycerol were associated with triacylglyceride 466 
content in the liver. Interestingly, diacylglycerol species were as well noted as relevant 467 
biomarkers by overfeeding experiments in humans[41], and phosphatidic acid increases 468 
considerably during diet-induced nonalcoholic fatty liver disease [51]. Further, these data 469 
reinforce the usefulness of plasma lipidomic signature for minimally invasive monitoring 470 
of liver status  [52]. 471 
 472 
Even though we detect no changes in some circulating surrogates of insulin resistance 473 
(such as fructosamine), we were able to detect molecular markers of adipose tissue and 474 
liver insulin resistance.  Sphingolipids were found among the measured markers 475 
correlating with HOMA-IR and insulin. This relationship agrees with the well-described 476 
role of ceramide signaling in human obesity-related insulin resistance (reviewed in[53]). 477 
Globally, this association would reinforce the validity of this model in evaluating the 478 
pathophysiology of obesity-related metabolic rearrangements. In line with this, and 479 
similar to humans, fat depots showed a location-specific response to high-calorie diet in 480 
the expression of glucose transporters and adipogenic proteins (as SREBP-1c). Further, 481 
AT leptin expression was increased, in line with adipose tissue expansion. 482 
 483 
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The changes in circulating metabolome and transcriptome also support the usefulness 484 
of the model: changes in BCAA metabolism have been described in several clinical 485 
studies, demonstrating that its alteration could predict diabetes development[54]. These 486 
variations can be associated with ongoing inflammation and with mitochondrial 487 
alterations, though in our model, no evidence for inflammation was found. Interestingly, 488 
we also found pieces of evidence for altered pantothenic-related metabolic pathways in 489 
our model of obesity. This concept fits with recently described findings in Yucatan mini-490 
pigs fed with a high-fat,high-sucrose diet for two months, also reporting amino acid 491 
metabolism changes, reduced capacities of BCAA transamination, and alteration in 492 
pantothenic metabolism [55]. In line with these results, transcriptomic changes in PBMC 493 
agree with previous data in humans. Thus, previous data in adipocytes reveal that EGR 494 
function, related to one of the pathways found in the transcriptome, is required to 495 
enhance triacylglyceride depot [56]. In mice, EGR represses FOXC2 expression and is 496 
required for the development of obesity under high-calorie intake. Of note, it is known 497 
that insulin inhibits EGR expression in peripheral cells [57]. Therefore, one could see 498 
EGR changes in PBMC as early markers for insulin dysfunction. Similarly, KRT18 has 499 
been invoked as a biomarker for obesity-related hepatic dysfunction in obese 500 
adolescents [58], so our finding of its change in this model would support its use as a 501 
preclinical model of human pubertal obesity. Functional neighborhood analyses revealed 502 
ubiquitin ligases DTX4 and DTX1 and the methyltransferase SUV420h2 as potential 503 
nodes of interest, as previously reported data on adipocyte differentiation and diet-504 
induced obesity reveals [59,60]. These results reinforce the usefulness of PBMC 505 
transcriptome analyses in this model. 506 
  507 
We assume, as limitations of the present work, that only using a single-gender could 508 
hinder the application of those results to human pathophysiology, especially those 509 
related to the influence of sex hormones in lipid metabolism. However, the fact that many 510 
markers were replicated in a completely independent fashion in a human cohort (with 511 
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both genders and older age) with obesity supports the usefulness of the chosen 512 
approach. Further, we acknowledge that a more thorough examination of this cohort 513 
(e.g., at older ages) would be advantageous to define the unique features of 514 
prepubescent obesity in this context. Based on the comparative analyses with the human 515 
cohort, we propose that those markers in common with consolidated obesity could show 516 
some promise in the pathophysiological research of increased AT depots. In contrast, 517 
those not in common with humans could be either derived from specific porcine 518 
metabolism, from younger age of examined specimens, or related to resilience towards 519 
pathological effects of AT buildup. Although the number of calories consumed is much 520 
higher in comparison with humans (both in the conventional and in the western-type 521 
diet), the experimental group exhibited a marked increase in daily intake of calories. 522 
Further, on the qualitative side, experimental diets modeling western-type diets include 523 
those such as the “cafeteria diet” with high-calorie content, high sucrose, and fat 524 
contents, with lower protein amounts [61,62]). These also include high fat with high 525 
cholesterol content[63]. Other authors also include a low fiber component[64]. Despite 526 
this diversity, our model shows most of these traits, reproducing the western-type dietary 527 
patterns. Further, lipidomic identification proposed aims at level 2, according to the 528 
Metabolomics Standards Initiative [65], so they are putatively annotated compounds 529 
(e.g., without chemical reference standards, based upon physicochemical properties and 530 
spectral similarity with public/commercial spectral libraries). Therefore, some of these 531 
reported metabolites might vary in their final identification., Noteworthy, our model of 532 
prepubescent obesity may be useful for the evaluation of the biological basis of 533 
metabolically healthy obesity.  A high proportion of obese children are metabolically fit 534 
[66]in a close relationship with a higher propensity of subcutaneous fat accumulation. 535 
Our model shows both a high subcutaneous fat accumulation concurrently with a non-536 
marked inflammatory response. Further, some of the circulating lipids correlate with 537 
physiological responses to AT expansion (e.g., leptin expression), while some others 538 
correlate with pathological traits (inflammatory markers or the HOMA-IR). This fact 539 
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reveals the mixed nature of lipidomic responses to western-type diet in this model, but 540 
we think that the reported data could be of interest in order to get the full profit of this 541 
model as a bona fide preclinical surrogate of pubertal obesity. 542 
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FIGURE LEGENDS 788 
 789 
Figure 1. A western-type diet induces prepubertal obesity, and it defines a specific 790 
lipidomic signature in plasma. A) Representative CT images of the porcine model of prepuberal 791 
obesity showing accumulation of AT in animals under a western-type diet. B) Example of 792 
determination of subcutaneous fat (red), intermuscular fat (green), and flare fat, including pelvic-793 
renal depot (orange) from CT images. C) Hierarchical clustering and heatmap shows a plasma 794 
lipidomic signature of high-calorie (western-type diet) in the porcine model. In the right panel, the 795 
PLS-DA model using plasma lipidomics demonstrates high accuracy (>65%, R2=0.99) in 796 
classification. Selected lipids are significantly associated with individual calorie intake (D), global 797 
fat abundance (E), and pelvic-rrenal fat abundance (F) as measured by CT in vivo. Shown lipids 798 
are a selection from those showing a significant correlation with specific traits (at least p<0.05 by 799 
Spearman’s rank correlation test, lines indicate non-linear fit (exponential growth equations; 800 
Y=Y0*exp(k*X)).   see Supplemental Data for the whole list). 801 
 802 
Figure 2. The prepubescent obesity model described induces changes in circulating 803 
insulin levels and its action, in association with specific plasma lipids and with changes 804 
in AT insulin-regulated proteins. Association of plasma concentration of selected lipids with 805 
individual insulin concentrations and HOMA-IR values (A). B shows a representative western-blot 806 
of insulin-responsive signals in AT and the influence of western-type diet. Right graphs after each 807 
blot show densitometric integrated values normalized to the intensity of animals fed with 808 
conventional diets all adjusted to total protein content, estimated by Coomassie blue staining, 809 
with p values after Students t-test. Considering all values from each protein, with a two way 810 
ANOVA significant differences were found as well for Glut2 in the subcutaneous depot, and for 811 
SREBP1 in omental and pelvic-renal depots (p<0.05, p<0.01 and p<0.02 respectively by post hoc 812 
analyses, n ranging 3 to 9 different samples). C) Subcutaneous adipose tissue leptin mRNA levels 813 
are associated with specific circulating lipids. D) Venn diagram showing the specificity of 814 
correlations, based on the very low (or absent) overlap between circulating lipids associated (at 815 
least p<0.05 by Spearman’s rank correlation test) with HOMA-IR, with subcutaneous adipose 816 
tissue leptin mRNA, and with fat content. Shown lipids in A and C are a selection from those 817 
showing significant correlation with these specific traits (at least p<0.05 by Spearman’s rank 818 
 28 
correlation test, lines indicate non-linear fit (exponential growth equations; Y=Y0*exp(k*X), see 819 
Supplemental Data for the whole list) 820 
 821 
Figure 3. Liver insulin-responsive signals and relationship with circulating lipidome. A) 822 
Representative western-blot of insulin-responsive signals in the liver with * in Glut 2 indicating 823 
differences induced by western-type diet (p<0.05 by Student’s t-test). B) Liver triacylglyceride 824 
(TAG) levels are associated with specific circulating lipids. C) Venn diagram showing the 825 
specificity of correlations, based on the very low (or absent) overlap between circulating lipids 826 
associated (at least p<0.05 by Spearman’s rank correlation test) with hepatic TAG levels, with 827 
HOMA-IR, with subcutaneous adipose tissue leptin mRNA and with fat content. Shown lipids in 828 
B are a selection from those showing significant correlation with specific traits (at least p<0.05 by 829 
Spearman’s rank correlation test, lines indicate non-linear fit (exponential growth equations; 830 
Y=Y0*exp(k*X)), see Supplemental Data for the whole list) 831 
 832 
Figure 4. Validation in humans with obesity of proposed biomarkers.  Specific lipids show a 833 
similar positive correlation with BMI (in humans, in B, D, and F) and AT abundance (in the porcine 834 
model, in A, C, and E). The same is presented for HOMA-IR correlations (for pigs in G and 835 
humans in H). All correlations are significant (at least p<0.05) by Spearman’s rank correlation 836 
test. Lines indicate non-linear fit (exponential growth equations; Y=Y0*exp(k*X)). Pig icon comes 837 
from aLf; and Human one by Ma Qing both from the Noun Project (thenountproject.com) 838 
 839 
Figure 5. Interactomics of plasma metabolites associated with a western-type diet. 840 
Metabolites were mapped to a pathway database (in this case, KEGG), and nodes, representing 841 
pathways (identified by pathway name in the database), is proportional to the number of 842 
metabolites contained in the pathway. Node color intensity is associated with the hypergeometric 843 
test accounting number of metabolites associated with high-calorie diet and those potentially 844 
present in the specific pathway (node), while edge width represents the percentage of shared 845 
metabolites between pathways and edge color indicate the number of metabolites associated 846 
with western-type diet. 847 
 848 
 29 
Table 1. Morphological, calorie consumption and biochemical traits  849 
Parameter Conventional diet Western-type diet p1 
Initial weight (Kg) 16.5±2.8 16.7±2.2 0.86 
Final weight (Kg) 53.2±5.7 60±8.36 0.043 
Weight gain 
(Kg/d) 
0.58±0.06 0.68±0.1 0.024 
Caloric 
consumption 
(Kcal/d) 
3819.7±236.5 5213.9±516.8 <0.0001 
Fecal fat content 
(mg/g) 
19.5±1.3 50±8 0.02 
Pelvico-renal fat 
weight (Kg) 
0.188±0.026 0.405±0.082 0.008 
Relative fat 
volume at VL2 
(%) 
12.7±1.2 19.4±2.6 0.002 
Blood Cholesterol 
(mg/dL) 
125.9±24.4 155.7±26.4 0.015 
Blood LDL-
Cholesterol 
(mg/dL) 
46.8±8.1 57.1±8.5 0.011 
Blood HDL-
Cholesterol 
(mg/dL) 
45.2±9.9 61.3±13.8 0.007 
Triacylglyceridemi
a 
(mg/dL) 
21.6±6.3 29.2±5.9 0.014 
Glycemia 
(mg/dL) 
80.75±16.73 108.6±23.9 0.01 
Fructosamine 
(mg/dL) 
177.6±24.9 152.1±46.8 0.131 
Insulinemia 
(pg/mL) 
5.65±0.24 5.77±0.46 0.26 
HOMA-IR 
 
1.09±0.21 1.56±0.39 0.009 
Values shown are mean±SD, unless stated otherwhise. 1Student’s t test 850 
comparison between values in in conventional and western-type diets 851 
 852 





EXTENDED METHODS 1 
Chemicals  2 
For lipidomic analyses and other analytical procedures, synthetic lipids were obtained from 3 
Avanti Polar Lipids Inc. (Alabaster, AL, USA) and Sigma-Aldrich (Madrid, Spain). Methyl tert-4 
butyl ether (MTBE), acetonitrile, potassium chloride, chloroform, ammonium formate and 5 
ammonium hydroxide -all liquid chromatography-mass spectrometry (LC-MS) grade- were 6 
purchased from Sigma-Aldrich (Madrid, Spain); methanol was from Carlo Erba (Milano, Italy); 7 
acetone was from Riedel-de-Häen (Seelze, Germany); and LC/MS-grade isopropanol and 8 
formic acid were from Baker (Phillipsburg, NJ, USA). 9 
 10 
Computed tomography scanning and image analysis 11 
Previously to the scan, animals were fasted for 16 h and anesthetized with azaperone (0.1 12 
mg/kg body weight (BW)), ketamine (0.2 mg/kg BW), and, if necessary, propofol (0.22 mg/kg 13 
BW) as explained in [1]. Pigs were scanned in the prone position, and acquisition parameters 14 
were axial, 1 s, 140 kV, 145 mA, 5 mm thickness, matrix 512x512, and displayed field of view 15 
adapted to the size of each pig. Scanning lasted approximately 20 min per pig. For each pig, 16 
one axial image was obtained at the level of the 2nd lumbar vertebrae (2VL). 17 
Images were analyzed with the software VisualPork [2,3] developed by the University of 18 
Girona and IRTA. Image analysis was those explained in ValLaillet et al. [4] modified. Thus, 19 
the mean and standard deviation of the Hounsfield (HU) value of the subcutaneous fat were 20 
obtained from each image. These values were used for the determination of the fat tissue 21 
content. From each image, an ROI (region of interest) was determined that considered all the 22 
outlines of the pig (ROI1), i.e., the total area of the image. Another area was taken at for the 23 
interior part of the subcutaneous fat of each image (ROI2), which corresponds to the area of 24 
the image, excluding subcutaneous fat and skin. Another area was obtained, including all the 25 
intraabdominal region, being the ribs, and the tenderloin the borders (ROI3). Finally, 26 
intraperitoneal area, going through the junction between flare fat and internal organs (ROI4), 27 
was determined. For each ROI (from ROI1 to ROI4), the AT area was calculated, considering 28 
the range of HU values between the mean HU value plus/minus two standard deviations 29 
previously determined. These areas were transformed into mm3, considering the DFOV, the 30 
matrix size, and the thickness [5]. From the volume of ROI1 minus those from ROI2, the 31 
subcutaneous fat was obtained. Intermuscular fat was obtained as the fat volume in ROI2 32 
minus ROI3 and flare fat as the fat volume of ROI3 minus those of ROI4. The ratio between 33 
the volume of the total fat (subcutaneous, intermuscular, and flare fat) and the total volume of 34 
the image was determined and converted into a percentage (relative fat volume at VL2).  35 
 36 
Samples were homogenized in a buffer containing 180 mM KCl, five mM MOPS, two mM 37 
EDTA, one mM diethylenetriaminepentaacetic acid, and one μM butylated hydroxyl toluene, 38 
10 μg/ml aprotinin, one mM NaF, one mM Na3VO4 and a protease inhibitor mix (GE 39 
Healthcare 80-6501-23, USA) (1% v/v) with a Potter-Elvehjem device, at 4 °C. After brief 40 
centrifugation (500 × g, 5 min) protein concentrations were measured in the supernatants 41 
using the Bradford protein assay (BioRad Laboratories, München, Germany). Tissue protein 42 
(15-40 mg) was resolved by SDS-PAGE and electroblotted onto polyvinylidene difluoride 43 
membranes (Immobilon-P, Millipore, Bedford, USA). Immunodetection was performed using 44 
as primary and secondary antibodies, those listed in Supplemental Table 6. A monoclonal 45 
antibody to β-actin (Sigma, USA) and Coomassie blue staining were used to control protein 46 
loading. Protein bands were visualized with the chemiluminescence ECL method (Millipore 47 
Corporation, Billerica, MA, USA). Luminescence was recorded and quantified in Lumi-Imager 48 
equipment from Boehringer (Mannheim, Germany), using the Quantity One 4.6.5. Software. 49 
Lipidomic analyses 50 
Preparation of Lipid Standards Lipid standards consisting of isotopically labeled lipids (see 51 
Supplemental Table 7) were used for external standardization (i.e., lipid family assignment) 52 
and internal standardization (i.e., for adjustment of potential inter- and intra-assay variances). 53 
Stock solutions were prepared by dissolving lipid standards in MTBE at a concentration of 54 
1mg/mL, and working solutions were diluted to 2.5μg/mL in MTBE. 55 
 Lipid extraction Briefly, in order to precipitate plasma protein fraction, 5μl of Mili Q water and 56 
20μl of methanol were added to 10μl of a plasma sample. After the addition, samples were 57 
vigorously shaken for 2 min. Then, for lipid extraction, 250μl of MTBE (containing internal lipid 58 
standards) were added, and samples were immersed in a water bath (ATU Ultrasonidos, 59 
Valencia, Spain) with an ultrasound frequency and power of 40kHz and 100W, respectively, 60 
at 10°C for 30 min. Then, 75 μL of Mili Q water was added to the mixture, and the organic 61 
phase was separated by centrifugation (1,400 x g) at 10 °C for 10 min. Lipid extracts contained 62 
in the upper phase were collected and subjected to mass spectrometry. A pool of all lipid 63 
extracts was prepared and used as quality controls, as previously described [6]. 64 
 65 
LC-MS/MS method Sample compartment was refrigerated at 4°C, and for each sample, 10μl 66 
of lipid extract was applied onto 1.8 µm particle 100 x 2.1 mm id Waters Acquity HSS T3 67 
column (Waters, Milford, MA, USA) heated to 55°C. The flow rate was 400μl/min with solvent 68 
A composed of 10mM ammonium acetate in acetonitrile-water (40:60, v/v) and solvent B 69 
composed of 10mM ammonium acetate in acetonitrile-isopropanol (10:90, v/v). The gradient 70 
started at 40% B and reached 100% B in 10min and held for 2 min. Finally, the system was 71 
switched back to 60% B and equilibrated for 3min. Duplicate runs of the samples were 72 
performed to collect positive and negative electrospray ionized lipid species in a TOF mode, 73 
operated in full-scan mode at 100 to 3000m/z in an extended dynamic range (2 GHz), using 74 
N2 as nebulizer gas (5L/min, 350°C). The capillary voltage was set 3500 V with a scan rate of 75 
1scan/s. Continuous infusion using a double spray with masses 121.050873, 922.009798 76 
(positive ion mode), and 119.036320, 966.000725 (negative ion mode) was used for in-run 77 
calibration of the mass spectrometer.  78 
Untargeted metabolomics analyses of serum 79 
For extraction of metabolites, 1.8ml of a methanol/water 8:1 (v/v) was added to 200 µl of serum 80 
sample. After stirring for 1 min and centrifugation (1400 x g) for 10 min at 4ºC, the supernatant 81 
with water-soluble metabolites was placed into a new vial, and the pellet was washed twice 82 
with additional methanol/water. The combined upper-phases solutions were partially dried 83 
under N2 flow until methanol removal. Finally, the solution was quickly frozen and lyophilized. 84 
 85 
The LC-MS analysis of aqueous serum extract samples was done using a Q-TOF/MS 6550 86 
mass spectrometer (Agilent Technologies) with an Agilent UPLC 1290 chromatographic 87 
system.  The lyophilized samples were reconstituted by adding 200 µl of 0.1% formic acid in 88 
water and injected onto a 1.8 µm particle 50 x 2.1 mm id Zorbax SB-Aq RR column (Agilent 89 
Technologies) which was heated to 60ºC in the column oven. A binary gradient system 90 
consisting of 0.2% acetic acid in water (solvent A) and 0.2% acetic acid in methanol (solvent 91 
B) was used. The flow rate was 0.5 mL/min, and the solvent gradient program was 0 to 1 min 92 
2% B isocratic, 1 to 13 min 98% B, 13 to 19 min 98% B isocratic, 1 min 0% B, and then 93 
equilibrated for an additional 5 min. The autosampler temperature was maintained at 4ºC, and 94 
the injection volume was 10 µl. 95 
Ionization was performed in an electrospray source mode, with a drying gas temperature and 96 
a flow of 150ºC and 14 mL/min, respectively; a sheath gas temperature and flow of 300ºC and 97 
11 mL/min, respectively; a nebulizer pressure of 30 psi; a capillary voltage of 3,000 V; and a 98 
nozzle voltage of 500 V. QTOF was operated in MS Full Scan mode in positive polarity, 99 
applying a fragmentary voltage of 380 V, an acquisition rate of 5 spectra/s and an acquisition 100 
range from 50 to 1700 m/z. Blank samples and quality control samples were injected regularly 101 
between the runs to ensure the quality of the data.  102 
Peripheral blood monocyte cells (PBMC) and AT transcriptomics  103 
Briefly, PBMCs were isolated from animal blood by Ficoll gradient separation (GE Healthcare, 104 
Piscataway, NJ, USA) and PBMC total RNA was extracted using Tripure Reagent (Roche 105 
Diagnostic, Barcelona, Spain) and purified with Qiagen RNeasy Mini Kit spin columns (Izasa, 106 
Barcelona, Spain). Blood samples (10 mL) were diluted (1:1) with phosphate buffer saline (pH: 107 
7.4), and PBMC were isolated by Ficoll gradient separation, according to the instructions 108 
indicated by the manufacturer (GE Healthcare Bio Sciences). The PBMC pellet was carefully 109 
resuspended with 4 mL of erythrocyte lysis buffer (155 mM NH4Cl, ten mM KHCO3, and 100 110 
µM EDTA, pH: 7.4), incubated at room temperature for 5 minutes and centrifuged at 400 g for 111 
10 minutes. Finally, the supernatant was aspirated, and the PBMC pellet was stored at -70°C 112 
until RNA analysis. PBMC total RNA was extracted using Tripure Reagent (Roche Diagnostic) 113 
and purified with Qiagen RNeasy Mini Kit spin columns (Izasa). RNA quantity was measured 114 
spectrophotometrically (NanoDrop®), and RNA quality was confirmed with the Agilent 2100 115 
Bioanalyzer (Agilent Technologies). 116 
 117 
The gene expression levels were assessed using Porcine (V2) Gene Expression Microarray, 118 
4x44K (Agilent Technologies) following the manufacturer's instructions. This microarray 119 
quantifies 43,603 probe sets. Labeling and hybridization of the samples were performed 120 
following Agilent One-color Microarray-Based Gene Expression Analysis-Low Input Quick 121 
Amp Labelling kit v6.6 protocol. Arrays were scanned with a G2565A Microarray Scanner 122 
System with SureScan High-Resolution Technology, and spot intensities were quantified 123 
using Feature Extraction 11.5.1.1 (Agilent Technologies, Inc. Santa Clara, CA). Background 124 
correction and inter-array normalization were performed with GeneSpring software v12.6.1 125 
(Agilent Technologies). Gene expression summaries were created for each gene by averaging 126 
all probe sets for each gene. All data analysis was conducted on gene-summarized data. 127 
Processed data were subsequently filtered for significant detection (P-value ≤ 0.01).  128 
 129 
Quantitative analyses of selected mRNA in subcutaneous AT was performed as previously 130 
described [7]. Briefly, RNA was prepared from tissue samples using an RNeasy Lipid Tissue 131 
Mini Kit (Izasa). The integrity of each RNA sample was checked by an Agilent Bioanalyzer 132 
(Agilent Technologies). Total RNA was quantified by the use of a spectrophotometer 133 
(GeneQuant; GE Healthcare) and reverse transcribed to cDNA using a High Capacity cDNA 134 
Archive Kit (Applied Biosystems Inc., Madrid, Spain) according to the manufacturer's protocol. 135 
Gene expression was assessed by real-time PCR using a LightCycler 480 Real-Time PCR 136 
System (Roche Diagnostics) using TaqMan® technology suitable for relative gene expression 137 
quantification.  138 
139 
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Supplemental Figure 1. Robustness of the PLS-DA model defining changes induced by a 165 
western-type diet (Figure 1 in the main text) is ensured by high accuracy, R2, and Q2 values. 166 
Variable importance in the projection of the first component demonstrates the importance of 167 
specific lipid molecules in plasma in helping to define a lipidomic signature associated with 168 
diet-induced obesity in prepubertal female pigs. 169 
 170 
Supplemental Figure 2. Biochemical and morphological traits define an obesity signature in 171 
the proposed model of prepubertal obesity. A) PLS-DA model demonstrating a high accuracy 172 
of the model, with more than 30% of variance being explained by the first component. B) 173 
Hierarchical clustering and heatmap shows that conventional (clinical biochemistry) and CT 174 
measures define a signature induced by western-type diet and demonstrate fat depot 175 
segregation according to anatomical location and clusterization with biochemical traits. C) 176 
Variable importance in projection (VIP) Scores of biochemical and morphological traits in the 177 
first component of the PLS-DA model. D) Permutation test of the model, showing a global p-178 
value with a 0.09 value. 179 
 180 
Supplemental Figure 3. Plasma LDL cholesterol values are associated with specific plasma 181 
lipids. Association of plasma concentration of selected lipids with LDL-cholesterol 182 
concentration. Shown lipids are a selection from those showing a significant correlation with 183 
specific traits (at least p<0.05 by Spearman's rank correlation test, see Supplemental Data for 184 
the whole list), while lines indicate non-linear fit (exponential growth equations; 185 
Y=Y0*exp(k*X). 186 
  187 
 188 
 189 
Supplemental Figure 4. A) Western-type diet does not increase lipid content in the liver, 190 
nor triacylglyceride (TAG) concentrations or cholesterol levels  B)  shows a representative 191 
western-blot of insulin-activity modulating signals in the liver and the influence of western-192 
type diet. Right graphs after each blot show densitometric integrated values normalized to 193 
the total protein content, estimated by Coomassie blue staining, with p values after Students 194 
t-test (n=6 for each group) 195 
 196 
 197 
 198 
Supplemental Figure 5. Skeletal muscle insulin-responsive signals are not affected by 199 
the western-type diet in the prepubertal model. Representative western-blot of insulin-200 
responsive signals in skeletal muscle. Right graphs show densitometric integrated values, 201 
normalized to the intensity of animals fed with conventional diets all adjusted to total protein 202 
content, estimated by Coomassie blue staining, with p values after Students t-test 203 
 204 
Supplemental Figure 6. Peripheral markers of inflammation are associated with specific 205 
plasma lipids. Association of plasma concentration of selected lipids with individual IL1a (A), 206 
IL1b (B) and IL-18 (C) Shown lipids are a selection from those showing significant correlation 207 
with specific traits (at least p<0.05 by Spearman's rank correlation test, see Supplemental 208 
Data for the whole list) while lines indicate non-linear fit (exponential growth equations; 209 
Y=Y0*exp(k*X). 210 
 211 
 212 
Supplemental Figure 7. Validation in humans with obesity of proposed biomarkers.  Specific 213 
lipids show a similar positive correlation with BMI (in humans, in B and D) and AT abundance 214 
(in the porcine model, in A and C).. All correlations are significant (at least p<0.05) by 215 
Spearman’s rank correlation test. Lines show the linear relationship, with R2 and p values for 216 
linear adjustment shown in the inset. Pig icon comes from aLf; and Human one by Ma Qing 217 
both from the Noun Project (thenountproject.com) 218 
 219 
Supplemental Figure 8. Induced network module analyses of PBMC transcriptomic changes 220 
associated with the western-type diet. Genes (see main text) were entered into the 221 
ConsensusPathDB platform, and interactions, coded by colors link nodes, representing 222 
entities (identified by colors). Black node labels denote genes significantly influenced by high-223 
calorie diet, while magenta node labels denote intermediate nodes. All types of protein 224 
interactions (high to low confidence protein interactions) were considered, as well as genetic, 225 
biochemical, and gene regulatory interactions, with all available database sources in the 226 
platform being considered. 227 
 228 
Supplemental Figure 9. Network neighborhood-based entity sets of PBMC transcriptomic 229 
changes associated with western-type diet. Genes (see main text) were entered into 230 
ConsensusPathDB platform, and nodes, representing neighborhood-based entity sets (whose 231 
size is proportional to the number of genes of the set, and color intensity denotes p-value for 232 
hypergeometric tests) are linked by interactions consisting of the number of genes shared by 233 
nodes.  The type of network chosen was 2-next neighbors, with a mínimum number of 2 genes 234 
from PBMC transcriptome overlap with members of the entity set (and a p<0.001 as the cutoff). 235 
The sets were obtained considering only Reactome based ones, with gene ontology level 5 236 
categories and a p-value cutoff of 0.01 for ontology inclusión. The upper panel indicates the 237 
statistical values of each entity set. 238 
 239 
 240 
Supplemental Figure 10. Interatomic analyses of PBMC transcriptome changes. 241 
Genes whose expression was changed by western-type diet in PBMC were introduced 242 
into the Genemania platform, together with PEMT and SRBEP1, in order to evaluate 243 
its potential clustering. The results (A) show five significant co-expression networks 244 
and co-localization, with PEMT and SRBEP1 being localized into a network with EGR2 245 
and KRT18. 246 
  247 
 248 
Supplemental Table 1. Clinical characteristics of the cohort used for translational 249 
applicability. 250 
Parameter Value1 
N 44 
Age 49.41±8.71 
Gender 52% female 
BMI (Kg/m2) 35.04±10.7 
Waist to hip ratio 0.90±0.11 
HOMA-IR 3.08±3.07 
Blood Cholesterol (mg/dL) 196.2±40.35 
Blood LDL-Cholesterol (mg/dL) 122.9±34.6 
Blood HDL-Cholesterol (mg/dL) 54.6±15.5 
Glycemia (mg/dL) 94.2±12.5 
Triacylglyceridemia (mg/dL) 95.5±49.49 
1Values shown are mean±SD unless stated otherwise. 251 
 252 
Supplemental Table 2. Composition of experimental diets applied from 9 to 11 weeks 253 
of age  254 
 255 
   
Component(%) Conventional transition Western-type transition 
Oats 66.00 - 
Wheat - 42.00 
Maize - 16.00 
Soy protein concentrate - - 
Hydrolyzed rice protein - - 
Caseinate 10.96 9.88 
Starch 1.00 10.00 
Saccharose - 5.00 
Wheat bran 15.00 4.00 
Soybean hulls 4.10 - 
Lard - 10.00 
Dicalcium phosphate 1.18 1.52 
Calcium carbonate 0.98 0.51 
Salt 0.35 0.37 
L-Lysine-HCl - 0.19 
L-Threonine - 0.03 
DL-Methionine - 0.10 
L-Tryptophan - - 
Ethoxiquin 0.02 0.02 
Vit-Min complex (*) 0.40 0.40 
(*) Provides per kg feed: vitamin A (E-672) 5500 UI; vitamin D3 (E-671) 1100 UI; vitamin E (alfa-tocopherol) 7 mg; vitamin B1 0.5 256 
mg; vitamin B2 1.4 mg; vitamin B6 1 mg; vitamin B12 8 µg; vitamin K3 0.5 mg; calcium panthotenate 5.6 mg; nicotinic acid 8 mg; 257 
choline 120 mg; Fe (E-1) (from FeSO4·7H2O) 80 mg; I (E-2) (from Ca(I2O3)2) 0.5 mg; Co (E-3) (from 2CoCO3·3Co(OH)2·H2O) 258 
0.4 mg; Cu ( E-4) (from CuSO4·5H2O) 5 mg; Cu (E-4) (from amino acids quelate) 5 mg; Mn (E-5) (from MnO) 40 mg; Zn (E-6) 259 
(from ZnO) 100 mg; Se (E-8) (from Na2SeO3) 0.25 mg. 260 
Supplemental Table 3. Nutritional composition of experimental diets applied from 9 261 
to 11 weeks of age  262 
Amount (%) Conventional transition Western-type transition 
Crude Protein 17.98 15.55 
Crude Fibre 12.20 1.68 
Fat 4.98 11.80 
Ash 5.96 4.15 
Sodium 0.15 0.15 
Chloride 0.29 0.31 
Total calcium 0.86 0.70 
Total phosphorous 0.58 0.49 
Digestible phosphorous 0.27 0.27 
Lysine 1.11 1.03 
Threonine 0.75 0.65 
Methionine 0.41 0.44 
Met+Cys 0.69 0.64 
Tryptophan 0.26 0.22 
Energy (MJ ME/kg) 10.42 15.39 
   
 263 
Supplemental Table 4. Composition of experimental diets applied from 12 to 19 264 
weeks of age  265 
Component(%) Conventional Western-type 
Oats 55.28 - 
Wheat - 45.87 
Maize - 13.56 
Caseinate 9.76 8.54 
Starch 13.13 10.00 
Saccharose - 5.00 
Wheat bran 15.00 4.00 
Soybean hulls 4.00 - 
Lard - 10.00 
Dicalcium phosphate 1.27 1.51 
Calcium carbonate 0.78 0.51 
Salt 0.36 0.37 
Ethoxiquin 0.02 0.02 
L-Lysine-HCL - 0.15 
L-Threonine - 0.01 
DL-Methinonine 0.003 0.07 
Vit-Min complex (*) 0.40 0.40 
(*) Provides per kg feed: vitamin A (E-672) 5500 UI; vitamin D3 (E-671) 1100 UI; vitamin E (alfa-tocopherol) 7 mg; vitamin B1 0.5 mg; 266 
vitamin B2 1.4 mg; vitamin B6 1 mg; vitamin B12 8 µg; vitamin K3 0.5 mg; calcium panthotenate 5.6 mg; nicotinic acid 8 mg; choline 120 267 
mg; Fe (E-1) (from FeSO4·7H2O) 80 mg; I (E-2) (from Ca(I2O3)2) 0.5 mg; Co (E-3) (from 2CoCO3·3Co(OH)2·H2O) 0.4 mg; Cu ( E-4) 268 
(from CuSO4·5H2O) 5 mg; Cu (E-4) (from amino acids quelate) 5 mg; Mn (E-5) (from MnO) 40 mg; Zn (E-6) (from ZnO) 100 mg; Se (E-8) 269 
(from Na2SeO3) 0.25 mg. 270 
 271 
  272 
Supplemental Table 5. Nutritional composition of experimental diets applied from 12 273 
to 19 weeks of age  274 
Amount(%) Conventional Western-type 
Protein 17.6 14.34 
Fat 4.6 11.55 
Fiber 11 1.72 
Sodium 0.15 0.15 
Chloride 0.29 0.31 
Calcium 0.80 0.70 
Total phosphorous 0.56 0.49 
Digestible phosphorous 0.27 0.27 
Lysine 0.99 0.90 
Threonine 0.66 0.57 
Methionine 0.36 0.37 
Met+Cys 0.61 0.56 
Tryptophan 0.23 0.20 
Ash 5.55 4.13 
Energy (MJ/ kg) 10.83 15.16 
 275 
 276 
  277 
 278 
Supplemental Table 6. Antibodies and conditions. 279 
 280 
Antigen Supplier Reference Dilution 
GLUT2 Abcam ab104622 1:1000 
SREBP1 Abcam ab3259 1:1000 
GLUT4 Invitrogen MA1-83191 1:1000 
AMPKα Invitrogen PA5-17398 1:1000 
Phospho-IRS1 (Ser 
307) 
Upstate 07-247 1:1000 
Phospho-IRS1 (Ser 
1101) 
Cell Signaling 2385 1:300 
Phospho-c-JUN 
(Ser73) 
Cell Signaling 3270 1:1000 
anti-mouse IgG Amersham NA931V 1:30000 
anti-rabbit IgG Pierce 31460 1:100000 
 281 
  282 
Supplemental Table 7. Internal standards for lipidomic analyses. 283 
 284 
Compound Reference 
1,3(d5)-dihexadecanoyl-glycerol 110537, Avanti Polar 
Lipids 
1,3(d5)-dihexadecanoyl-2-octadecanoyl-glycerol 110543, Avanti Polar 
Lipids 
1-hexadecanoyl(d31)-2-(9Z-octadecenoyl)-sn-
glycero-3-phosphate 
110920, Avanti Polar 
Lipids 
1-hexadecanoyl(d31)-2-(9Z-octadecenoyl)-sn-
glycero-3-phosphocholine 
110918, Avanti Polar 
Lipids 
1-hexadecanoyl(d31)-2-(9Z-octadecenoyl)-sn-
glycero-3-phosphoethanolamine 
110921, Avanti Polar 
Lipids 
1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
phospho-(1'-rac-glycerol-1',1',2',3',3'-d5) 
110899, Avanti Polar 
Lipids 
1-hexadecanoyl(d31)-2-(9Z-octadecenoyl)-sn-
glycero-3-phospho-myo-inositol 
110923, Avanti Polar 
Lipids 
1-hexadecanoyl(d31)-2-(9Z-octadecenoyl)-sn-
glycero-3-[phospho-L-serine] 
110922, Avanti Polar 
Lipids 
26:0-d4 Lyso PC 860389, Avanti Polar 
Lipids 
18:1 Cholesterol (d7) ester 111015, Avanti Polar 
Lipids 
cholest-5-en-3ß-ol(d7) LM-4100, Avanti Polar 
Lipids 
D-erythro-sphingosine-d7 860657, Avanti Polar 
Lipids 
D-erythro-sphingosine-d7-1-phosphate 860659, Avanti Polar 
Lipids 
N-palmitoyl-d31-D-erythro-sphingosine 868516, Avanti Polar 
Lipids 
N-palmitoyl-d31-D-erythro-
sphingosylphosphorylcholine 
868584, Avanti Polar 
Lipids 
Octadecanoic acid-2,2-d2 19905-58-9, Sigma Aldrich 
 285 
 286 
 287 
Supplemental Table 8 . Changes in subcutaneous AT mRNA concentration induced 288 
by the western-type diet. 289 
 290 
Gene Conventional1 Western-type Change (%) p-value 
lep 0.0225 ± 0.0152 0.064 ± 0.0215 184.8 <0.00001 
Il6 0.0072 ± 0.0079 0.0032 ± 0.0015 -55.7 0.15 
Irs1 0.0635 ± 0.0291 0.0464 ± 0.0199 -26.9 0.158 
fasn  5.4763 ± 1.732 5.5608 ± 1.4093 1.5 0.908 
adipoq 126.87 ± 71.05 94.71 ± 34.74 -25.3 0.211 
Insr1 1.05 ± 0.22 1.13 ± 0.22 7.6 0.455 
gapdh 17.77 ± 4.53 20.9 ± 7.29 17.6 0.247 
 1Values shown are mean±SD unless stated otherwise. 291 
    292 
  293 
Supplemental Table 9. Changes in plasma interleukine concentration induced by the 294 
western-type diet. 295 
Parameter 
(pg/mL) 
Conventional Western-type p1 
IL-1a 0.016.9±0.014 0.014±0.019 
 
0.9 
IL-1b 0.054±0.047 0.056±0.061 0.9 
IL-1ra 0.13±0.12 0.11±0.11 0.6 
IL-10 0.08±0.12 0.09±0.16 0.9 
IL-18 0.43±0.31 0.48±0.36 0.9 
 296 
Values shown are mean±SD unless stated otherwise. 1Student’s t-test comparison 297 
between values in conventional and western-type  diets 298 
  299 
Supplemental Table 10. Changes in plasma metabolome induced by western-type 300 
diet 301 
Compound Log 
FC 
p  p 
(Corr)  
Regulation 
(Conventiona
l versus 
western-type)  
FC 
(Control 
vs High 
Calorie) 
Leucine -0.44 8.22E
-04 
2.73E
-02 
Up 1.36 
Pantheine -1.35 1.51E
-04 
8.38E
-03 
Up 2.55 
N-ethylarachidonoyl amine -
14.7
3 
2.16E
-04 
1.09E
-02 
Up 27116.8
1 
N-Lignoceroylsphingosine -0.94 9.37E
-04 
3.01E
-02 
Up 1.92 
3alpha,6alpha,7alpha,12alpha
-Tetrahydroxy-5beta-cholest-
24-en-26-oic acid 
13.9
3 
1.30E
-05 
9.63E
-04 
Down -
15602.2
2 
GlnMetGln 14.4
7 
4.82E
-08 
6.85E
-06 
Down -
22617.4
6 
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